Table 5.
Control (33°C) (n = 12) |
LBH (48°C) (n = 11) |
|||
---|---|---|---|---|
30 min | 120 min | 30 min | 120 min | |
NOS3 | 1.07 ± 0.11 | 1.38 ± 0.25 | 1.16 ± 0.06 | 1.50 ± 0.14 |
PPARGC1A | 1.18 ± 0.08 | 1.27 ± 0.16 | 1.32 ± 0.06 | 1.21 ± 0.03 |
MMP2 | 0.99 ± 0.07 | 1.17 ± 0.12 | 0.98 ± 0.07 | 1.07 ± 0.08 |
TIMP1 | 0.89 ± 0.09 | 1.18 ± 0.22 | 1.12 ± 0.11 | 0.97 ± 0.07 |
TEK | 1.09 ± 0.11 | 1.30 ± 0.16 | 1.17 ± 0.05 | 1.23 ± 0.06 |
CXCL12 | 0.98 ± 0.06 | 0.97 ± 0.06 | 0.98 ± 0.03 | 0.93 ± 0.03 |
NCL | 1.05 ± 0.05 | 1.03 ± 0.04 | 1.09 ± 0.04 | 0.96 ± 0.03 |
FOXO3 | 1.31 ± 0.06 | 1.34 ± 0.07 | 1.43 ± 0.11 | 1.28 ± 0.11 |
IL6 | 0.73 ± 0.14 | 0.66 ± 0.14 | 0.65 ± 0.08 | 0.62 ± 0.06 |
HSPA1A | 0.80 ± 0.05 | 0.73 ± 0.08 | 1.06 ± 0.10 | 0.93 ± 0.08 |
Biopsy samples were taken at baseline and 30 and 120 min following the completion of the interventions.